FDA Inspection 862841 — Vitalant

Vitalant — FEI 2571073

The FDA completed an inspection of Vitalant on January 22, 2014 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 22, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)

Citations

IDCFRDescription
921921 CFR 606.100(b)(20)Donor deferral